News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Carisma Therapeutics, co-founded by Saar Gill, MD, PhD, Associate Professor of Medicine at Penn Medicine, is merging with OrthoCellix.
Gemma plans to establish manufacturing and research centers in Abu Dhabi.
Eli Lilly has acquired Verve Therapeutics, a startup co-founded by Kiran Musunuru.
Dispatch Bio, co-founded by Carl June, MD, the Richard W. Vague Professor in Immunotherapy at Penn Medicine, is developing a universal cancer treatment for solid tumors.
Kite Therapeutics, a Gilead Company, has entered into a definitive agreement to acquire Interius Therapeutics .
AbbVie acquired Capstan, including its lead asset CPTX2309.
Penn I-Corps invites faculty, staff, postdocs, and students working on life science innovations to apply to the Special Bio/Medtech I-Corps Customer Discovery Workshop.
PCI, Pennovation Works and Philadelphia Alliance for Capital & Technologies (PACT) hosted the “Innovate & Inspire: Research Panel & Pitch Competition” in May.
Fajgenbaum discovered a treatment for Castleman Disease using an existing drug.
Levine co-wrote the inspirational song "Ring that Bell" with country artist Mags McCarthy.